News
Partial Results of AI Radiotherapy Trial for Head and Neck Cancer with Tohoku Medical and Pharmaceutical University Receive JRS2025 Excellence Award
A case report based on a social implementation trial of AI-assisted radiation therapy for head and neck cancer, conducted in collaboration with Tohoku Medical and Pharmaceutical University as part of the Advanced Technology Use Case Promotion Program supported by the City of Sendai, was presented by Dr. Nishiyama, a medical student at the university. The […]
Release of DICOMRT Anonymization Tool
We are pleased to announce the release of RatoAnonymizer, a software tool designed to safely anonymize personal information contained in DICOMRT files.It supports the secure secondary use of DICOM data in clinical and research settings.The software is available free of charge with no restrictions. You can download it from the following page: Download Page
AiRato acquired first class medical devices marketing license in Japan.
We are pleased to announce that Airato, Inc (Headquarters: Sendai City, Miyagi Prefecture, Representative Directors: Yuto Kimura and Noriyuki Kadoya) obtained a license for “Type 1 Medical Device Manufacturing and Sales Business” from Miyagi Prefecture on February 21, 2025. The acquisition of this business license is based on the provisions of Article 23-2, Paragraph 1 […]
A case report from Tohoku Medical and Pharmaceutical University has been published on the results of a social implementation trial of AI-based radiation therapy planning for head and neck cancer.
A partial result of the social implementation test of AI radiation therapy planning for head and neck cancer, which was conducted with the support of Sendai City’s Advanced Technology Use Case Creation Support Project, has been published as a case report paper by Tohoku Medical and Pharmaceutical University (led by Dr. Ishikawa, the on-site treating […]